Dan Marquess
CIK 1734423 · Chief Scientific Officer · last filed 2020-06-24
Dan Marquess is a Chief Scientific Officer who has filed 4 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing shows the insider had shares withheld for taxes covering $24.0K of UBX on Jun 24, 2020.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Unity Biotechnology, Inc. (UBX) Delisted | Chief Scientific Officer | 380,690 | $0.20 | $76.2K | $0 | 4 | 2020-06-24 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-24 | Unity Biotechnology, Inc. (UBX) Delisted | Tax (F) | −2,483 | -$24.0K | EDGAR |
| 2020-04-01 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | +24,255 | $0 | EDGAR |
| 2019-06-24 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | +21,075 | $0 | EDGAR |
| 2018-05-04 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | — | $0 | EDGAR |